Breadcrumb Home Yale Technologies Mitotherapeutix: Using siMCJ to treat MCJ-based Metabolic Disorders Yale Innovation Summit - Day 1 05/18/2021 Mitotherapeutix: Using siMCJ to treat MCJ-based Metabolic Disorders Download Pitch Presentation Talley, Jack.pdf (3.73 MB) Investigators Jack Talley CEO
